ImageneBio Inc (IMA) Total Return Calculator with Dividends Reinvested

ImageneBio Inc

Popular:

The total return for ImageneBio Inc (IMA) stock is -66.98% over the past 12 months. So far it's down 19.69% this year. The 5-year total return is -96.70%, meaning $10,000 invested in IMA stock 5 years ago would be worth $330 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in IMA 1 year ago, it would be worth $3,351 today — you'd have lost $6,649.

With Dividends Reinvested$3,351-66.49%

Price Only (No DRIP)$3,351-66.49%

Period2025-06-13 → 2026-06-12

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in IMA

1Y$3,302-$6,698 (-67.0%)-67.0% CAGR

3Y$670-$9,330 (-93.3%)-59.4% CAGR

5Y$330-$9,670 (-96.7%)-49.5% CAGR

10Y$141-$9,859 (-98.6%)-34.7% CAGR

15Y$141-$9,859 (-98.6%)-24.7% CAGR

20Y$141-$9,859 (-98.6%)-19.2% CAGR

30Y$141-$9,859 (-98.6%)-13.2% CAGR

ImageneBio Inc did not pay dividends during this period. Total return = price return.

Loading IMA total return...

As of 2026-06-13

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-19.69%	—	-19.69%	—	$8,031
1Y	-66.98%	-66.98%	-66.98%	—	$3,302
3Y	-93.30%	-59.38%	-93.30%	—	$670
5Y	-96.70%	-49.47%	-96.70%	—	$330
10Y	-98.59%	-34.68%	-98.59%	—	$141
15Y	-98.59%	-24.72%	-98.59%	—	$141
20Y	-98.59%	-19.18%	-98.59%	—	$141
30Y	-98.59%	-13.23%	-98.59%	—	$141

Risk & Highlights

Best Year-17.59%2024

Worst Year-80.72%2022

Max Drawdown-74.58%2025-07-31 → 2026-04-06

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-0.59%	-0.59%	—	+0.41%	-1.0pp
2025	-65.15%	-65.15%	—	+16.64%	-81.8pp
2024	-17.59%	-17.59%	—	+24.00%	-41.6pp
2023	-24.81%	-24.81%	—	+24.81%	-49.6pp
2022	-80.72%	-80.72%	—	-19.95%	-60.8pp

IMA underperformed the S&P 500 by 89.83pp over the past year (-66.98% vs +22.86%).

Loading summary...

IMA Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
IMAImageneBio Inc	$61M	-5.1%	-19.7%	-67.0%	—	-93.3%	-96.7%	-98.6%
SRZNSurrozen, Inc.	$175M	-23.7%	+8.5%	+148.8%	—	+149.5%	-84.2%	-84.6%
IMVTImmunovant, Inc.	$6.9B	+17.3%	+29.8%	+110.9%	—	+55.0%	+213.0%	+237.9%
KYMRKymera Therapeutics, Inc.	$7.0B	+3.2%	+18.5%	+82.3%	—	+242.9%	+70.4%	+159.2%
ARQTArcutis Biotherapeutics, Inc.	$3.0B	+17.8%	-15.9%	+80.6%	—	+138.8%	-16.2%	+11.8%
PRTAProthena Corporation plc	$432M	-12.5%	-10.3%	+62.7%	—	-88.7%	-82.7%	-82.0%
ALNYAlnylam Pharmaceuticals, Inc.	$37.7B	-3.1%	-29.3%	-7.2%	—	+46.5%	+69.7%	+366.4%
RAREUltragenyx Pharmaceutical Inc.	$2.4B	-9.3%	+3.2%	-38.0%	—	-52.6%	-76.3%	-59.4%
FOLDAmicus Therapeutics, Inc.	$4.5B	—	+1.5%	+134.8%	—	+11.6%	+35.2%	+147.3%
ACADACADIA Pharmaceuticals Inc.	$3.6B	-2.9%	-19.3%	-3.0%	—	-14.3%	-22.6%	-44.6%
PTCTPTC Therapeutics, Inc.	$6.2B	+0.2%	-2.1%	+47.4%	—	+73.3%	+71.1%	+995.3%

Compare:IMA vs SRZN IMA vs IMVT IMA vs KYMR IMA vs SRZN vs IMVT

About IMA Dividend Returns

ImageneBio Inc (IMA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of IMA over the past year?

ImageneBio Inc (IMA) delivered a return of -66.98% over the past year. Since IMA does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in IMA be worth today?

A $10,000 investment in ImageneBio Inc one year ago would be worth $3,302 today, representing a loss of $6,698.

Q3Does IMA pay dividends?

ImageneBio Inc (IMA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For IMA, the total return equals the price-only return.

Q4Did IMA beat the S&P 500?

No, ImageneBio Inc (IMA) underperformed the S&P 500 by 89.83 percentage points over the past year. IMA delivered a total return of -66.98%, compared to the S&P 500's 22.86%. This means a passive S&P 500 index fund outperformed IMA by 89.83pp during this period.

Q5What is IMA's worst drawdown?

ImageneBio Inc (IMA) experienced a maximum drawdown of -74.58% over the past year, declining from its peak on 2025-07-31 to its trough on 2026-04-06. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is IMA's long-term total return over 10, 20, or 30 years?

Here are ImageneBio Inc (IMA)'s long-term returns with dividends reinvested. Over 10 years, the total return is -98.6% (-34.7% CAGR) — $10,000 would have grown to $141. Over 20 years: -98.6% total return (-19.2% CAGR) — $10,000 → $141. Over 30 years: -98.6% total return (-13.2% CAGR) — $10,000 → $141. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was IMA's best and worst year?

ImageneBio Inc's best calendar year was 2024 with a total return of -17.6%. Its worst year was 2022 with a total return of -80.7%. This range shows the volatility investors should expect — the difference between the best and worst year is 63.1 percentage points.

How much would $100/month in IMA be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →